Application Sponsors
ANDA 214695 | ALKEM LABS LTD | |
Marketing Status
Prescription | 001 |
None (Tentative Approval) | 002 |
None (Tentative Approval) | 003 |
None (Tentative Approval) | 004 |
Application Products
001 | UNKNOWN | UNKNOWN | 0 | LACOSAMIDE | LACOSAMIDE |
002 | TABLET;ORAL | 100MG | 0 | LACOSAMIDE | LACOSAMIDE |
003 | TABLET;ORAL | 150MG | 0 | LACOSAMIDE | LACOSAMIDE |
004 | TABLET;ORAL | 200MG | 0 | LACOSAMIDE | LACOSAMIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | TA | 2021-03-25 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
004 | Prescription | AB |
CDER Filings
ALKEM LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 214695
[companyName] => ALKEM LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"LACOSAMIDE","activeIngredients":"LACOSAMIDE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"03\/25\/2021","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-03-25
)
)